Ranolazine for the Treatment of Chest Pain in HCM Patients

Summary

The purpose of RHYME is to evaluate the safety and efficacy of ranolazine in Hypertrophic Cardiomypathy patients with chest pain or dyspnea despite treatment with standard medical therapy. This is a small, pilot, open-label (non-randomized) study of an approved drug for the treatment of angina in a novel patient population (adult patient population with hypertrophic cardiomyopathy).

Timeline

Start

2012-11

Primary completion

2015-11

Completion

2016-05

Drugs

Indications